Global Recombinant Therapeutic Protein Market Insights and Forecast to 2031

Report ID: 1228439 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Recombinant Therapeutic Protein Product Introduction
    1.2 Market by Type
        1.2.1 Global Recombinant Therapeutic Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Recombinant Human Collage
        1.2.3 Recombinant Human Serum Albumin
    1.3 Market by Application
        1.3.1 Global Recombinant Therapeutic Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Medicine
        1.3.3 Scientific Research
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Recombinant Therapeutic Protein Sales Estimates and Forecasts 2017-2028
    2.2 Global Recombinant Therapeutic Protein Revenue Estimates and Forecasts 2017-2028
    2.3 Global Recombinant Therapeutic Protein Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Recombinant Therapeutic Protein Sales by Region
        2.4.1 Global Recombinant Therapeutic Protein Sales by Region (2017-2022)
        2.4.2 Global Sales Recombinant Therapeutic Protein by Region (2023-2028)
    2.5 Global Recombinant Therapeutic Protein Revenue by Region
        2.5.1 Global Recombinant Therapeutic Protein Revenue by Region (2017-2022)
        2.5.2 Global Recombinant Therapeutic Protein Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Recombinant Therapeutic Protein Sales by Manufacturers
        3.1.1 Global Top Recombinant Therapeutic Protein Manufacturers by Sales (2017-2022)
        3.1.2 Global Recombinant Therapeutic Protein Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Therapeutic Protein in 2021
    3.2 Global Recombinant Therapeutic Protein Revenue by Manufacturers
        3.2.1 Global Recombinant Therapeutic Protein Revenue by Manufacturers (2017-2022)
        3.2.2 Global Recombinant Therapeutic Protein Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Recombinant Therapeutic Protein Revenue in 2021
    3.3 Global Recombinant Therapeutic Protein Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Recombinant Therapeutic Protein Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Recombinant Therapeutic Protein Sales by Type
        4.1.1 Global Recombinant Therapeutic Protein Historical Sales by Type (2017-2022)
        4.1.2 Global Recombinant Therapeutic Protein Forecasted Sales by Type (2023-2028)
        4.1.3 Global Recombinant Therapeutic Protein Sales Market Share by Type (2017-2028)
    4.2 Global Recombinant Therapeutic Protein Revenue by Type
        4.2.1 Global Recombinant Therapeutic Protein Historical Revenue by Type (2017-2022)
        4.2.2 Global Recombinant Therapeutic Protein Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Recombinant Therapeutic Protein Revenue Market Share by Type (2017-2028)
    4.3 Global Recombinant Therapeutic Protein Price by Type
        4.3.1 Global Recombinant Therapeutic Protein Price by Type (2017-2022)
        4.3.2 Global Recombinant Therapeutic Protein Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Recombinant Therapeutic Protein Sales by Application
        5.1.1 Global Recombinant Therapeutic Protein Historical Sales by Application (2017-2022)
        5.1.2 Global Recombinant Therapeutic Protein Forecasted Sales by Application (2023-2028)
        5.1.3 Global Recombinant Therapeutic Protein Sales Market Share by Application (2017-2028)
    5.2 Global Recombinant Therapeutic Protein Revenue by Application
        5.2.1 Global Recombinant Therapeutic Protein Historical Revenue by Application (2017-2022)
        5.2.2 Global Recombinant Therapeutic Protein Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Recombinant Therapeutic Protein Revenue Market Share by Application (2017-2028)
    5.3 Global Recombinant Therapeutic Protein Price by Application
        5.3.1 Global Recombinant Therapeutic Protein Price by Application (2017-2022)
        5.3.2 Global Recombinant Therapeutic Protein Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Recombinant Therapeutic Protein Market Size by Type
        6.1.1 North America Recombinant Therapeutic Protein Sales by Type (2017-2028)
        6.1.2 North America Recombinant Therapeutic Protein Revenue by Type (2017-2028)
    6.2 North America Recombinant Therapeutic Protein Market Size by Application
        6.2.1 North America Recombinant Therapeutic Protein Sales by Application (2017-2028)
        6.2.2 North America Recombinant Therapeutic Protein Revenue by Application (2017-2028)
    6.3 North America Recombinant Therapeutic Protein Market Size by Country
        6.3.1 North America Recombinant Therapeutic Protein Sales by Country (2017-2028)
        6.3.2 North America Recombinant Therapeutic Protein Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Recombinant Therapeutic Protein Market Size by Type
        7.1.1 Europe Recombinant Therapeutic Protein Sales by Type (2017-2028)
        7.1.2 Europe Recombinant Therapeutic Protein Revenue by Type (2017-2028)
    7.2 Europe Recombinant Therapeutic Protein Market Size by Application
        7.2.1 Europe Recombinant Therapeutic Protein Sales by Application (2017-2028)
        7.2.2 Europe Recombinant Therapeutic Protein Revenue by Application (2017-2028)
    7.3 Europe Recombinant Therapeutic Protein Market Size by Country
        7.3.1 Europe Recombinant Therapeutic Protein Sales by Country (2017-2028)
        7.3.2 Europe Recombinant Therapeutic Protein Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Recombinant Therapeutic Protein Market Size by Type
        8.1.1 Asia Pacific Recombinant Therapeutic Protein Sales by Type (2017-2028)
        8.1.2 Asia Pacific Recombinant Therapeutic Protein Revenue by Type (2017-2028)
    8.2 Asia Pacific Recombinant Therapeutic Protein Market Size by Application
        8.2.1 Asia Pacific Recombinant Therapeutic Protein Sales by Application (2017-2028)
        8.2.2 Asia Pacific Recombinant Therapeutic Protein Revenue by Application (2017-2028)
    8.3 Asia Pacific Recombinant Therapeutic Protein Market Size by Region
        8.3.1 Asia Pacific Recombinant Therapeutic Protein Sales by Region (2017-2028)
        8.3.2 Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Recombinant Therapeutic Protein Market Size by Type
        9.1.1 Latin America Recombinant Therapeutic Protein Sales by Type (2017-2028)
        9.1.2 Latin America Recombinant Therapeutic Protein Revenue by Type (2017-2028)
    9.2 Latin America Recombinant Therapeutic Protein Market Size by Application
        9.2.1 Latin America Recombinant Therapeutic Protein Sales by Application (2017-2028)
        9.2.2 Latin America Recombinant Therapeutic Protein Revenue by Application (2017-2028)
    9.3 Latin America Recombinant Therapeutic Protein Market Size by Country
        9.3.1 Latin America Recombinant Therapeutic Protein Sales by Country (2017-2028)
        9.3.2 Latin America Recombinant Therapeutic Protein Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Recombinant Therapeutic Protein Market Size by Type
        10.1.1 Middle East and Africa Recombinant Therapeutic Protein Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Recombinant Therapeutic Protein Revenue by Type (2017-2028)
    10.2 Middle East and Africa Recombinant Therapeutic Protein Market Size by Application
        10.2.1 Middle East and Africa Recombinant Therapeutic Protein Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Recombinant Therapeutic Protein Revenue by Application (2017-2028)
    10.3 Middle East and Africa Recombinant Therapeutic Protein Market Size by Country
        10.3.1 Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Recombinant Therapeutic Protein Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Boehringer Ingelheim
        11.1.1 Boehringer Ingelheim Corporation Information
        11.1.2 Boehringer Ingelheim Overview
        11.1.3 Boehringer Ingelheim Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Boehringer Ingelheim Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Boehringer Ingelheim Recent Developments
    11.2 Bristol-Myers Squibb
        11.2.1 Bristol-Myers Squibb Corporation Information
        11.2.2 Bristol-Myers Squibb Overview
        11.2.3 Bristol-Myers Squibb Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bristol-Myers Squibb Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bristol-Myers Squibb Recent Developments
    11.3 Celldex Therapeutics
        11.3.1 Celldex Therapeutics Corporation Information
        11.3.2 Celldex Therapeutics Overview
        11.3.3 Celldex Therapeutics Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Celldex Therapeutics Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Celldex Therapeutics Recent Developments
    11.4 Eli Liily
        11.4.1 Eli Liily Corporation Information
        11.4.2 Eli Liily Overview
        11.4.3 Eli Liily Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Eli Liily Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Eli Liily Recent Developments
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Corporation Information
        11.5.2 GlaxoSmithKline Overview
        11.5.3 GlaxoSmithKline Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 GlaxoSmithKline Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 GlaxoSmithKline Recent Developments
    11.6 Merck
        11.6.1 Merck Corporation Information
        11.6.2 Merck Overview
        11.6.3 Merck Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Merck Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Merck Recent Developments
    11.7 Novartis
        11.7.1 Novartis Corporation Information
        11.7.2 Novartis Overview
        11.7.3 Novartis Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Novartis Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Novartis Recent Developments
    11.8 Regeneron Pharmaceuticals
        11.8.1 Regeneron Pharmaceuticals Corporation Information
        11.8.2 Regeneron Pharmaceuticals Overview
        11.8.3 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Regeneron Pharmaceuticals Recent Developments
    11.9 Roche
        11.9.1 Roche Corporation Information
        11.9.2 Roche Overview
        11.9.3 Roche Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Roche Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Roche Recent Developments
    11.10 Takeda
        11.10.1 Takeda Corporation Information
        11.10.2 Takeda Overview
        11.10.3 Takeda Recombinant Therapeutic Protein Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Takeda Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Takeda Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Recombinant Therapeutic Protein Industry Chain Analysis
    12.2 Recombinant Therapeutic Protein Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Recombinant Therapeutic Protein Production Mode & Process
    12.4 Recombinant Therapeutic Protein Sales and Marketing
        12.4.1 Recombinant Therapeutic Protein Sales Channels
        12.4.2 Recombinant Therapeutic Protein Distributors
    12.5 Recombinant Therapeutic Protein Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Recombinant Therapeutic Protein Industry Trends
    13.2 Recombinant Therapeutic Protein Market Drivers
    13.3 Recombinant Therapeutic Protein Market Challenges
    13.4 Recombinant Therapeutic Protein Market Restraints
14 Key Findings in The Global Recombinant Therapeutic Protein Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Recombinant Therapeutic Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Recombinant Human Collage
    Table 3. Major Manufacturers of Recombinant Human Serum Albumin
    Table 4. Global Recombinant Therapeutic Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Recombinant Therapeutic Protein Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Recombinant Therapeutic Protein Sales by Region (2017-2022) & (MT)
    Table 7. Global Recombinant Therapeutic Protein Sales Market Share by Region (2017-2022)
    Table 8. Global Recombinant Therapeutic Protein Sales by Region (2023-2028) & (MT)
    Table 9. Global Recombinant Therapeutic Protein Sales Market Share by Region (2023-2028)
    Table 10. Global Recombinant Therapeutic Protein Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Recombinant Therapeutic Protein Revenue Market Share by Region (2017-2022)
    Table 12. Global Recombinant Therapeutic Protein Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Recombinant Therapeutic Protein Revenue Market Share by Region (2023-2028)
    Table 14. Global Recombinant Therapeutic Protein Sales by Manufacturers (2017-2022) & (MT)
    Table 15. Global Recombinant Therapeutic Protein Sales Share by Manufacturers (2017-2022)
    Table 16. Global Recombinant Therapeutic Protein Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Recombinant Therapeutic Protein Revenue Share by Manufacturers (2017-2022)
    Table 18. Recombinant Therapeutic Protein Price by Manufacturers (2017-2022) &(USD/MT)
    Table 19. Global Recombinant Therapeutic Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Recombinant Therapeutic Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Therapeutic Protein as of 2021)
    Table 21. Recombinant Therapeutic Protein Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Recombinant Therapeutic Protein Product Offered
    Table 23. Date of Manufacturers Enter into Recombinant Therapeutic Protein Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)
    Table 26. Global Recombinant Therapeutic Protein Sales by Type (2023-2028) & (MT)
    Table 27. Global Recombinant Therapeutic Protein Sales Share by Type (2017-2022)
    Table 28. Global Recombinant Therapeutic Protein Sales Share by Type (2023-2028)
    Table 29. Global Recombinant Therapeutic Protein Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Recombinant Therapeutic Protein Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Recombinant Therapeutic Protein Revenue Share by Type (2017-2022)
    Table 32. Global Recombinant Therapeutic Protein Revenue Share by Type (2023-2028)
    Table 33. Recombinant Therapeutic Protein Price by Type (2017-2022) & (USD/MT)
    Table 34. Global Recombinant Therapeutic Protein Price Forecast by Type (2023-2028) & (USD/MT)
    Table 35. Global Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)
    Table 36. Global Recombinant Therapeutic Protein Sales by Application (2023-2028) & (MT)
    Table 37. Global Recombinant Therapeutic Protein Sales Share by Application (2017-2022)
    Table 38. Global Recombinant Therapeutic Protein Sales Share by Application (2023-2028)
    Table 39. Global Recombinant Therapeutic Protein Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Recombinant Therapeutic Protein Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Recombinant Therapeutic Protein Revenue Share by Application (2017-2022)
    Table 42. Global Recombinant Therapeutic Protein Revenue Share by Application (2023-2028)
    Table 43. Recombinant Therapeutic Protein Price by Application (2017-2022) & (USD/MT)
    Table 44. Global Recombinant Therapeutic Protein Price Forecast by Application (2023-2028) & (USD/MT)
    Table 45. North America Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)
    Table 46. North America Recombinant Therapeutic Protein Sales by Type (2023-2028) & (MT)
    Table 47. North America Recombinant Therapeutic Protein Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Recombinant Therapeutic Protein Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)
    Table 50. North America Recombinant Therapeutic Protein Sales by Application (2023-2028) & (MT)
    Table 51. North America Recombinant Therapeutic Protein Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Recombinant Therapeutic Protein Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Recombinant Therapeutic Protein Sales by Country (2017-2022) & (MT)
    Table 54. North America Recombinant Therapeutic Protein Sales by Country (2023-2028) & (MT)
    Table 55. North America Recombinant Therapeutic Protein Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Recombinant Therapeutic Protein Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)
    Table 58. Europe Recombinant Therapeutic Protein Sales by Type (2023-2028) & (MT)
    Table 59. Europe Recombinant Therapeutic Protein Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Recombinant Therapeutic Protein Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)
    Table 62. Europe Recombinant Therapeutic Protein Sales by Application (2023-2028) & (MT)
    Table 63. Europe Recombinant Therapeutic Protein Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Recombinant Therapeutic Protein Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Recombinant Therapeutic Protein Sales by Country (2017-2022) & (MT)
    Table 66. Europe Recombinant Therapeutic Protein Sales by Country (2023-2028) & (MT)
    Table 67. Europe Recombinant Therapeutic Protein Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Recombinant Therapeutic Protein Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)
    Table 70. Asia Pacific Recombinant Therapeutic Protein Sales by Type (2023-2028) & (MT)
    Table 71. Asia Pacific Recombinant Therapeutic Protein Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Recombinant Therapeutic Protein Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)
    Table 74. Asia Pacific Recombinant Therapeutic Protein Sales by Application (2023-2028) & (MT)
    Table 75. Asia Pacific Recombinant Therapeutic Protein Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Recombinant Therapeutic Protein Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Recombinant Therapeutic Protein Sales by Region (2017-2022) & (MT)
    Table 78. Asia Pacific Recombinant Therapeutic Protein Sales by Region (2023-2028) & (MT)
    Table 79. Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)
    Table 82. Latin America Recombinant Therapeutic Protein Sales by Type (2023-2028) & (MT)
    Table 83. Latin America Recombinant Therapeutic Protein Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Recombinant Therapeutic Protein Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)
    Table 86. Latin America Recombinant Therapeutic Protein Sales by Application (2023-2028) & (MT)
    Table 87. Latin America Recombinant Therapeutic Protein Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Recombinant Therapeutic Protein Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Recombinant Therapeutic Protein Sales by Country (2017-2022) & (MT)
    Table 90. Latin America Recombinant Therapeutic Protein Sales by Country (2023-2028) & (MT)
    Table 91. Latin America Recombinant Therapeutic Protein Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Recombinant Therapeutic Protein Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Recombinant Therapeutic Protein Sales by Type (2017-2022) & (MT)
    Table 94. Middle East and Africa Recombinant Therapeutic Protein Sales by Type (2023-2028) & (MT)
    Table 95. Middle East and Africa Recombinant Therapeutic Protein Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Recombinant Therapeutic Protein Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Recombinant Therapeutic Protein Sales by Application (2017-2022) & (MT)
    Table 98. Middle East and Africa Recombinant Therapeutic Protein Sales by Application (2023-2028) & (MT)
    Table 99. Middle East and Africa Recombinant Therapeutic Protein Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Recombinant Therapeutic Protein Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2017-2022) & (MT)
    Table 102. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2023-2028) & (MT)
    Table 103. Middle East and Africa Recombinant Therapeutic Protein Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Recombinant Therapeutic Protein Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Boehringer Ingelheim Corporation Information
    Table 106. Boehringer Ingelheim Description and Major Businesses
    Table 107. Boehringer Ingelheim Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 108. Boehringer Ingelheim Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Boehringer Ingelheim Recent Developments
    Table 110. Bristol-Myers Squibb Corporation Information
    Table 111. Bristol-Myers Squibb Description and Major Businesses
    Table 112. Bristol-Myers Squibb Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 113. Bristol-Myers Squibb Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Bristol-Myers Squibb Recent Developments
    Table 115. Celldex Therapeutics Corporation Information
    Table 116. Celldex Therapeutics Description and Major Businesses
    Table 117. Celldex Therapeutics Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 118. Celldex Therapeutics Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Celldex Therapeutics Recent Developments
    Table 120. Eli Liily Corporation Information
    Table 121. Eli Liily Description and Major Businesses
    Table 122. Eli Liily Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 123. Eli Liily Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Eli Liily Recent Developments
    Table 125. GlaxoSmithKline Corporation Information
    Table 126. GlaxoSmithKline Description and Major Businesses
    Table 127. GlaxoSmithKline Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 128. GlaxoSmithKline Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. GlaxoSmithKline Recent Developments
    Table 130. Merck Corporation Information
    Table 131. Merck Description and Major Businesses
    Table 132. Merck Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 133. Merck Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Merck Recent Developments
    Table 135. Novartis Corporation Information
    Table 136. Novartis Description and Major Businesses
    Table 137. Novartis Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 138. Novartis Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Novartis Recent Developments
    Table 140. Regeneron Pharmaceuticals Corporation Information
    Table 141. Regeneron Pharmaceuticals Description and Major Businesses
    Table 142. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 143. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Regeneron Pharmaceuticals Recent Developments
    Table 145. Roche Corporation Information
    Table 146. Roche Description and Major Businesses
    Table 147. Roche Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 148. Roche Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Roche Recent Developments
    Table 150. Takeda Corporation Information
    Table 151. Takeda Description and Major Businesses
    Table 152. Takeda Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 153. Takeda Recombinant Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Takeda Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Recombinant Therapeutic Protein Distributors List
    Table 158. Recombinant Therapeutic Protein Customers List
    Table 159. Recombinant Therapeutic Protein Market Trends
    Table 160. Recombinant Therapeutic Protein Market Drivers
    Table 161. Recombinant Therapeutic Protein Market Challenges
    Table 162. Recombinant Therapeutic Protein Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Therapeutic Protein Product Picture
    Figure 3. Global Recombinant Therapeutic Protein Market Share by Type in 2021 & 2028
    Figure 3. Recombinant Human Collage Product Picture
    Figure 4. Recombinant Human Serum Albumin Product Picture
    Figure 5. Global Recombinant Therapeutic Protein Market Share by Application in 2021 & 2028
    Figure 6. Medicine
    Figure 7. Scientific Research
    Figure 8. Others
    Figure 9. Recombinant Therapeutic Protein Report Years Considered
    Figure 10. Global Recombinant Therapeutic Protein Sales 2017-2028 (MT)
    Figure 11. Global Recombinant Therapeutic Protein Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Recombinant Therapeutic Protein Revenue 2017-2028 (US$ Million)
    Figure 13. Global Recombinant Therapeutic Protein Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Recombinant Therapeutic Protein Sales Market Share by Region (2017-2022)
    Figure 15. Global Recombinant Therapeutic Protein Sales Market Share by Region (2023-2028)
    Figure 16. North America Recombinant Therapeutic Protein Sales YoY (2017-2028) & (MT)
    Figure 17. North America Recombinant Therapeutic Protein Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Recombinant Therapeutic Protein Sales YoY (2017-2028) & (MT)
    Figure 19. Europe Recombinant Therapeutic Protein Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Recombinant Therapeutic Protein Sales YoY (2017-2028) & (MT)
    Figure 21. Asia-Pacific Recombinant Therapeutic Protein Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Recombinant Therapeutic Protein Sales YoY (2017-2028) & (MT)
    Figure 23. Latin America Recombinant Therapeutic Protein Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Recombinant Therapeutic Protein Sales YoY (2017-2028) & (MT)
    Figure 25. Middle East & Africa Recombinant Therapeutic Protein Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Recombinant Therapeutic Protein Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Recombinant Therapeutic Protein in the World: Market Share by Recombinant Therapeutic Protein Revenue in 2021
    Figure 28. Global Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Recombinant Therapeutic Protein Sales Market Share by Type (2017-2028)
    Figure 30. Global Recombinant Therapeutic Protein Revenue Market Share by Type (2017-2028)
    Figure 31. Global Recombinant Therapeutic Protein Sales Market Share by Application (2017-2028)
    Figure 32. Global Recombinant Therapeutic Protein Revenue Market Share by Application (2017-2028)
    Figure 33. North America Recombinant Therapeutic Protein Sales Market Share by Type (2017-2028)
    Figure 34. North America Recombinant Therapeutic Protein Revenue Market Share by Type (2017-2028)
    Figure 35. North America Recombinant Therapeutic Protein Sales Market Share by Application (2017-2028)
    Figure 36. North America Recombinant Therapeutic Protein Revenue Market Share by Application (2017-2028)
    Figure 37. North America Recombinant Therapeutic Protein Sales Share by Country (2017-2028)
    Figure 38. North America Recombinant Therapeutic Protein Revenue Share by Country (2017-2028)
    Figure 39. U.S. Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Recombinant Therapeutic Protein Sales Market Share by Type (2017-2028)
    Figure 42. Europe Recombinant Therapeutic Protein Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Recombinant Therapeutic Protein Sales Market Share by Application (2017-2028)
    Figure 44. Europe Recombinant Therapeutic Protein Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Recombinant Therapeutic Protein Sales Share by Country (2017-2028)
    Figure 46. Europe Recombinant Therapeutic Protein Revenue Share by Country (2017-2028)
    Figure 47. Germany Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 48. France Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Recombinant Therapeutic Protein Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Recombinant Therapeutic Protein Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Recombinant Therapeutic Protein Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Recombinant Therapeutic Protein Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Recombinant Therapeutic Protein Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Recombinant Therapeutic Protein Revenue Share by Region (2017-2028)
    Figure 58. China Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 61. India Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Recombinant Therapeutic Protein Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Recombinant Therapeutic Protein Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Recombinant Therapeutic Protein Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Recombinant Therapeutic Protein Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Recombinant Therapeutic Protein Sales Share by Country (2017-2028)
    Figure 73. Latin America Recombinant Therapeutic Protein Revenue Share by Country (2017-2028)
    Figure 74. Mexico Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Recombinant Therapeutic Protein Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Recombinant Therapeutic Protein Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Recombinant Therapeutic Protein Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Recombinant Therapeutic Protein Revenue Share by Country (2017-2028)
    Figure 83. Turkey Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Recombinant Therapeutic Protein Revenue (2017-2028) & (US$ Million)
    Figure 86. Recombinant Therapeutic Protein Value Chain
    Figure 87. Recombinant Therapeutic Protein Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boehringer Ingelheim
Bristol-Myers Squibb
Celldex Therapeutics
Eli Liily
GlaxoSmithKline
Merck
Novartis
Regeneron Pharmaceuticals
Roche
Takeda
Frequently Asked Questions
Recombinant Therapeutic Protein report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Recombinant Therapeutic Protein report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Recombinant Therapeutic Protein report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

HER2 Antibody

HER2 Antibody market is segmented by players, region (country), by Type and by Application. Playe ... Read More

Trastuzumab

Trastuzumab market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

Pertuzumab

Pertuzumab market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More